User profiles for Michele Cea

michele cea

university of genoa
Verified email at unige.it
Cited by 5115

[HTML][HTML] Nutrients in the Prevention of Alzheimer's Disease

AL Cremonini, I Caffa, M Cea, A Nencioni… - … medicine and cellular …, 2019 - hindawi.com
Alzheimer’s disease (AD) is a disease caused by the complex interaction of multiple mechanisms,
some of which are still not fully understood. To date, pharmacological treatments and …

Regulation and function of extracellular nicotinamide phosphoribosyltransferase/visfatin

…, A Vecchiè, M Casula, M Cea… - Comprehensive …, 2011 - Wiley Online Library
Nicotinamide phosphoribosyltransferase (NAMPT) is an adipokine‐enzyme, which was
described as to play bioactivities both in the intracellular and in the extracellular environment. …

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and …

…, M Grasso, S Ballanti, A Spadano, M Cea… - The Lancet …, 2021 - thelancet.com
Background Bortezomib-based induction followed by high-dose melphalan (200 mg/m 2 )
and autologous stem-cell transplantation (MEL200-ASCT) and maintenance treatment with …

Fasting-mimicking diet and hormone therapy induce breast cancer regression

…, M Passalacqua, A Ballestrero, G Zoppoli, M Cea… - Nature, 2020 - nature.com
Approximately 75% of all breast cancers express the oestrogen and/or progesterone receptors.
Endocrine therapy is usually effective in these hormone-receptor-positive tumours, but …

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

…, C Acharya, MY Zhong, M Cea… - Blood, The Journal …, 2014 - ashpublications.org
B-cell maturation antigen (BCMA), highly expressed on malignant plasma cells in human
multiple myeloma (MM), has not been effectively targeted with therapeutic monoclonal …

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment

…, MY Zhong, X Feng, M Cea… - Blood, The Journal …, 2016 - ashpublications.org
Here we show that overexpression or activation of B-cell maturation antigen (BCMA) by its
ligand, a proliferation-inducing ligand (APRIL), promotes human multiple myeloma (MM) …

[HTML][HTML] Autophagy in blood cancers: biological role and therapeutic implications

A Nencioni, M Cea, F Montecucco, VD Longo… - …, 2013 - ncbi.nlm.nih.gov
Autophagy is a cell recycling process the molecular apparatus of which has been identified
over the past decade. Autophagy allows cells to survive starvation and inhospitable …

[HTML][HTML] Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE

…, A Garuti, A D'Urso, M Selmo, F Benvenuto, M Cea… - PloS one, 2009 - journals.plos.org
Nicotinamide phosphoribosyltransferase (Nampt) inhibitors such as FK866 are potent
inhibitors of NAD + synthesis that show promise for the treatment of different forms of cancer. …

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

…, J Lin, JJ Zhao, A Cagnetta, M Cea… - Blood, The Journal …, 2012 - ashpublications.org
Bruton tyrosine kinase (Btk) has a well-defined role in B-cell development, whereas its
expression in osteoclasts (OCs) further suggests a role in osteoclastogenesis. Here we …

[HTML][HTML] The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses

…, D Soncini, I Caffa, A Poggi, G Zoppoli, M Cea… - Journal of Biological …, 2012 - ASBMB
Cytokine secretion by cancer cells contributes to cancer-induced symptoms and angiogenesis.
Studies show that the sirtuin SIRT6 promotes inflammation by enhancing TNF expression…